The global tissue engineered collagen biomaterials market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for tissue engineered products in orthopedic and wound care applications, rising awareness about the benefits of these products, and technological advancements in the field.
The global tissue engineered collagen biomaterials market is segmented on the basis of type (bovine, porcine, marine, chicken), application (orthopedic and wound care), and region (North America, Latin America, Europe, Asia Pacific & Middle East & Africa). The bovine segment accounted for a share of over 50% in 2018 owing to its high availability and low cost. The porcine segment is expected to grow at a CAGR of 8.5% during the forecast period owing to its high availability and low cost.
-The global Tissue Engineered Collagen Biomaterials market is expected to grow at a CAGR of XX% during the forecast period.
-Tissue Engineered Collagen Biomaterials are used in various applications such as wound healing, bone regeneration, and cartilage repair.
-Collagen is the most abundant protein in the human body and it has been used for many years in medical applications such as skin grafting and bone reconstruction.
Industry Growth Insights published a new data on “Tissue Engineered Collagen Biomaterials Market”. The research report is titled “Tissue Engineered Collagen Biomaterials Market research by Types (Bovine, Porcine, Marine, Chicken, Others), By Applications (Orthopedic, Wound Care, Others), By Players/Companies Collagen Matrix Inc, Medtronic, Advanced BioMatrix Inc, Kyeron B.V., Collagen Matrix, Collagen Solutions Plc, CollPlant Ltd, Fraunhofer-Gesellschaft, GENOSS Co., Ltd, Maxigen Biotech Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tissue Engineered Collagen Biomaterials Market Research Report
By Type
Bovine, Porcine, Marine, Chicken, Others
By Application
Orthopedic, Wound Care, Others
By Companies
Collagen Matrix Inc, Medtronic, Advanced BioMatrix Inc, Kyeron B.V., Collagen Matrix, Collagen Solutions Plc, CollPlant Ltd, Fraunhofer-Gesellschaft, GENOSS Co., Ltd, Maxigen Biotech Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Tissue Engineered Collagen Biomaterials Market Report Segments:
The global Tissue Engineered Collagen Biomaterials market is segmented on the basis of:
Types
Bovine, Porcine, Marine, Chicken, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Orthopedic, Wound Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Collagen Matrix Inc
- Medtronic
- Advanced BioMatrix Inc
- Kyeron B.V.
- Collagen Matrix
- Collagen Solutions Plc
- CollPlant Ltd
- Fraunhofer-Gesellschaft
- GENOSS Co., Ltd
- Maxigen Biotech Inc
Highlights of The Tissue Engineered Collagen Biomaterials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bovine
- Porcine
- Marine
- Chicken
- Others
- By Application:
- Orthopedic
- Wound Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tissue Engineered Collagen Biomaterials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tissue Engineered Collagen Biomaterials (TECBs) are a class of materials that have been specifically designed to mimic the natural properties of collagen, the most abundant protein in the human body. TECBs can be used to improve tissue regeneration and repair, as well as reduce inflammation and scarring.
Some of the major players in the tissue engineered collagen biomaterials market are Collagen Matrix Inc, Medtronic, Advanced BioMatrix Inc, Kyeron B.V., Collagen Matrix, Collagen Solutions Plc, CollPlant Ltd, Fraunhofer-Gesellschaft, GENOSS Co., Ltd, Maxigen Biotech Inc.
The tissue engineered collagen biomaterials market is expected to grow at a compound annual growth rate of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tissue Engineered Collagen Biomaterials Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tissue Engineered Collagen Biomaterials Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tissue Engineered Collagen Biomaterials Market - Supply Chain
4.5. Global Tissue Engineered Collagen Biomaterials Market Forecast
4.5.1. Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tissue Engineered Collagen Biomaterials Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tissue Engineered Collagen Biomaterials Market Absolute $ Opportunity
5. Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Type
5.3.1. Bovine
5.3.2. Porcine
5.3.3. Marine
5.3.4. Chicken
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Application
6.3.1. Orthopedic
6.3.2. Wound Care
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tissue Engineered Collagen Biomaterials Demand Share Forecast, 2019-2026
9. North America Tissue Engineered Collagen Biomaterials Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Application
9.4.1. Orthopedic
9.4.2. Wound Care
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Type
9.7.1. Bovine
9.7.2. Porcine
9.7.3. Marine
9.7.4. Chicken
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tissue Engineered Collagen Biomaterials Demand Share Forecast, 2019-2026
10. Latin America Tissue Engineered Collagen Biomaterials Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Application
10.4.1. Orthopedic
10.4.2. Wound Care
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Type
10.7.1. Bovine
10.7.2. Porcine
10.7.3. Marine
10.7.4. Chicken
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tissue Engineered Collagen Biomaterials Demand Share Forecast, 2019-2026
11. Europe Tissue Engineered Collagen Biomaterials Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Application
11.4.1. Orthopedic
11.4.2. Wound Care
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Type
11.7.1. Bovine
11.7.2. Porcine
11.7.3. Marine
11.7.4. Chicken
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tissue Engineered Collagen Biomaterials Demand Share, 2019-2026
12. Asia Pacific Tissue Engineered Collagen Biomaterials Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Application
12.4.1. Orthopedic
12.4.2. Wound Care
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Type
12.7.1. Bovine
12.7.2. Porcine
12.7.3. Marine
12.7.4. Chicken
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tissue Engineered Collagen Biomaterials Demand Share, 2019-2026
13. Middle East & Africa Tissue Engineered Collagen Biomaterials Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Application
13.4.1. Orthopedic
13.4.2. Wound Care
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tissue Engineered Collagen Biomaterials Market Size and Volume Forecast by Type
13.7.1. Bovine
13.7.2. Porcine
13.7.3. Marine
13.7.4. Chicken
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tissue Engineered Collagen Biomaterials Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tissue Engineered Collagen Biomaterials Market: Market Share Analysis
14.2. Tissue Engineered Collagen Biomaterials Distributors and Customers
14.3. Tissue Engineered Collagen Biomaterials Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Collagen Matrix Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Advanced BioMatrix Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Kyeron B.V.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Collagen Matrix
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Collagen Solutions Plc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CollPlant Ltd
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fraunhofer-Gesellschaft
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GENOSS Co., Ltd
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Maxigen Biotech Inc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
